{"nct_id":"NCT02655237","title":"A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids","status":"COMPLETED","status_verified_date":"2018-12","start_date":"2016-03-05","start_date_type":"ACTUAL","primary_completion_date":"2017-05-17","primary_completion_date_type":"ACTUAL","completion_date":"2017-09-25","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}